Allogeneic Stem Cell Transplantation With Reduced Intensity Conditioning Regimen In Patients With Relapsed Hodgkin's Lymphoma

被引:0
|
作者
Rivas, Maria Marta
Berro, Mariano
Yantorno, Sebastian
Prates, Maria Virginia
Milone, Jorge H.
Basquiera, Ana Lisa
Berreta, Adriana
Garcia, Juan
Remaggi, Guillermina
Rolon, Juliana Martinez
Arbelbide, Jorge
Makiya, Monica
Dibar, Eduardo
Requejo, Alejandro
Feldman, Leonardo Julio, Sr.
Milovic, Vera
Foncuberta, Maria Cecilia
Burgos, Ruben
Kusminsky, Gustavo Daniel
机构
关键词
D O I
10.1182/blood.V122.21.5511.5511
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
5511
引用
收藏
页数:1
相关论文
共 50 条
  • [21] Conditioning Regimen Comparison for Allogeneic Stem Cell Transplantation in non-hodgkin Lymphoma
    Peterson, Kristen
    Lin, Andrew
    Ruiz, Josel
    Zheng, Junting
    Devlin, Sean
    Shah, Gunjan
    Scordo, Michael
    Sauter, Craig
    Perales, Miguel
    Giralt, Sergio
    Buie, Larry
    Dahi, Parastoo
    BONE MARROW TRANSPLANTATION, 2020, 55 (SUPPL 1) : 299 - 300
  • [22] Reduced-intensity allogeneic stem cell transplantation in relapsed and refractory Hodgkin's disease: low transplant-related mortality and impact of intensity of conditioning regimen on survival
    Anderlini, P
    Saliba, R
    Donato, M
    Andersson, B
    Ueno, N
    Khouri, I
    De Lima, M
    Ippoliti, C
    Champlin, R
    BONE MARROW TRANSPLANTATION, 2005, 35 : S11 - S11
  • [23] Impact of type of reduced-intensity conditioning regimen on the outcomes of allogeneic haematopoietic cell transplantation in classical Hodgkin lymphoma
    Ahmed, Sairah
    Ghosh, Nilanjan
    Ahn, Kwang W.
    Khanal, Manoj
    Litovich, Carlos
    Mussetti, Alberto
    Chhabra, Saurabh
    Cairo, Mitchell
    Mei, Matthew
    William, Basem
    Nathan, Sunita
    Bejanyan, Nelli
    Olsson, Richard F.
    Dahi, Parastoo B.
    van der Poel, Marjolein
    Steinberg, Amir
    Kanakry, Jennifer
    Cerny, Jan
    Farooq, Umar
    Seo, Sachiko
    Kharfan-Dabaja, Mohamed A.
    Sureda, Anna
    Fenske, Timothy S.
    Hamadani, Mehdi
    BRITISH JOURNAL OF HAEMATOLOGY, 2020, 190 (04) : 573 - 582
  • [24] Unrelated Donor Reduced-Intensity Allogeneic Hematopoietic Stem Cell Transplantation for Relapsed and Refractory Hodgkin Lymphoma
    Devetten, Marcel P.
    Hari, Parameswaran N.
    Carreras, Jeanette
    Logan, Brent R.
    van Besien, Koen
    Bredeson, Christopher N.
    Freytes, Cesar O.
    Gale, Robert Peter
    Gibson, John
    Giralt, Sergio A.
    Goldstein, Steven C.
    Gupta, Vikas
    Marks, David I.
    Maziorz, Richard T.
    Vase, Julie M.
    Lazarus, Hillard M.
    Anderlini, Paolo
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2009, 15 (01) : 109 - 117
  • [25] Fludarabine-meiphalan as a preparative regimen for reduced-intensity conditioning allogeneic stem cell transplantation in relapsed and refractory Hodgkin's lymphoma: the updated MD Anderson Cancer Center experience
    Anderlini, Paolo
    Saliba, Rima
    Acholonu, Sandra
    Giralt, Sergio A.
    Andersson, Borje
    Ueno, Naoto T.
    Hosing, Chitra
    Khouri, Issa F.
    Couriel, Daniel
    de Lima, Marcos
    Qazilbash, Muzaffar H.
    Pro, Barbara
    Romaguera, Jorge
    Fayad, Luis
    Hagemeister, Frederick
    Younes, Anas
    Munsell, Mark F.
    Champlin, Richard E.
    HAEMATOLOGICA, 2008, 93 (02) : 257 - 264
  • [26] Sustained response after reduced-intensity conditioning allogeneic stem cell transplantation for patients with relapsed peripheral T-cell non-Hodgkin lymphoma
    de lavallade, Hugues
    Cassier, Philippe A.
    Bouabdallah, Reda
    El-Cheikh, Jean
    Faucher, Catherine
    Fuerst, Sabine
    Coso, Diane
    Sainty, Danielle
    Arnoulet, Christine
    Gastaut, Jean-Albert
    Chetaille, Bruno
    Xerri, Luc
    Blaise, Didier
    Mohty, Mohamad
    BRITISH JOURNAL OF HAEMATOLOGY, 2008, 142 (05) : 848 - 850
  • [27] Reduced intensity conditioning and allogeneic stem cell transplantation after salvage therapy integrating alemtuzumab for patients with relapsed peripheral T-cell non-Hodgkin's lymphoma
    Wulf, GG
    Hasenkamp, J
    Jung, W
    Chapuy, B
    Truemper, L
    Glass, B
    BONE MARROW TRANSPLANTATION, 2005, 36 (03) : 271 - 273
  • [28] Reduced intensity conditioning and allogeneic stem cell transplantation after salvage therapy integrating alemtuzumab for patients with relapsed peripheral T-cell non-Hodgkin's lymphoma
    G G Wulf
    J Hasenkamp
    W Jung
    B Chapuy
    L Truemper
    B Glass
    Bone Marrow Transplantation, 2005, 36 : 271 - 273
  • [29] Reduced-intensity conditioning allogeneic stem cell transplantation for relapsed/refractory mantle cell lymphoma: a multicenter experience
    Le Gouill, S.
    Kroeger, N.
    Dhedin, N.
    Nagler, A.
    Bouabdallah, K.
    Yakoub-Agha, I.
    Kanouni, T.
    Bulabois, C. E.
    Tournilhac, O.
    Buzyn, A.
    Rio, B.
    Moles, M. P.
    Shimoni, A.
    Bacher, U.
    Ocheni, S.
    Milpied, N.
    Harousseau, J. L.
    Moreau, P.
    Leux, C.
    Mohty, M.
    ANNALS OF ONCOLOGY, 2012, 23 (10) : 2695 - 2703
  • [30] Reduced-intensity allogeneic stem cell transplantation for relapsed/refractory Hodgkin's lymphoma: no benefit of graft-versus-lymphoma effect
    Lerner, D.
    Arcuri, L.
    Maiolino, A.
    Sousa, A.
    Tavares, R.
    Colares, M.
    Matos, M.
    Azevedo, A.
    Bouzas, L. F.
    BONE MARROW TRANSPLANTATION, 2011, 46 : S250 - S251